Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Eupraxia Pharmaceuticals Inc. EPRX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • CA • USD

SharesGrow Score
54/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$19.00
+163.2%

Insider Transactions — EPRX

No insider transactions data available for EPRX.

People Also View

SLS
SLS
SELLAS Life Sciences Group, Inc.
$4.86
+2.10%
 GNFT
GNFT
Genfit S.A.
$8.95
+4.07%
 NAUT
NAUT
Nautilus Biotechnology, Inc.
$3.06
+3.03%
 IVA
IVA
Inventiva S.A.
$5.51
+9.98%
 OBIO
OBIO
Orchestra BioMed Holdings, Inc.
$4.51
+4.88%
 TARA
TARA
Protara Therapeutics, Inc.
$5.13
+1.18%
 MDWD
MDWD
MediWound Ltd.
$17.70
+0.28%
 RNAC
RNAC
Cartesian Therapeutics, Inc.
$6.35
+7.08%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message